Maves
Maves identifies Keeva Medical Group as its clinical partner for compounded treatments. Its individual products and bundles differ, while the older billing agreement still needs clarification.
Review by Leah Garner, clinical-evidence editor · Updated October 2026
The short version
The current consent clearly identifies the clinical group. Confirm the assigned professional and applicable billing terms before choosing a combined protocol.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Lowest listed: Sermorelin injection, from $199/mo
Visit Maves →Maves markets individual prescription treatments and bundles combining GLP-1 therapy, sermorelin and NAD. Its treatment pages describe compounded preparations, online assessment and home delivery. A combined protocol is a different purchase from each medicine separately; its price does not establish the independent cost or evidence for every ingredient.
What Maves prescribes, by goal
Weight
- SemaglutideFDA-approved
- Injection (compounded)From $249/mo
- TirzepatideFDA-approved
- Injection (compounded)From $349/mo
Semaglutide and tirzepatide pages describe weekly subcutaneous injections. A separate bundle pairs GLP-1 therapy with sermorelin, while a higher bundle adds NAD. An ingredient combination does not establish that muscle preservation or better weight loss has been demonstrated for that particular protocol.
Longevity
- NAD+Compounding conditions apply
- Injection (compounded)From $229/mo
NAD is offered by injection with broad energy and healthy-aging claims. The marketing does not establish a clinical outcome study for the preparation. Confirm the prescribed concentration, route and monitoring before relying on a general cellular-energy explanation.
Recovery
- SermorelinCompounding conditions apply
- Injection (compounded)From $199/mo
Sermorelin is described as a subcutaneous treatment with recovery, muscle and sleep claims. Ask what outcome is being treated and how response is assessed. A mechanism involving growth hormone does not establish the claimed improvement for every patient.
Sleep
- SermorelinCompounding conditions apply
- Injection (compounded)From $199/mo
Each “From” figure is the seller’s own starting price, in the unit the seller states. Where a required fee or a package length changes what one month costs, the smaller line under it is our arithmetic, not a figure the seller prints. Compounded preparations are not FDA-approved.
Who prescribes
A licensed clinician
The August 2026 telehealth consent identifies the Keeva Medical Group network and affiliated professional entities as responsible for clinical care. Homera Health operates the Maves platform and provides administrative support. The particular Keeva entity depends on the patient’s location. An assigned professional’s credentials can be reviewed, but no individual prescriber is established for every patient.
The current consent allows questionnaires, secure messages and live audio or video encounters. Keeva may request testing or in-person assessment when remote information is insufficient. Clinical decisions remain with the treating professional. Ask how routine reassessment and urgent questions are handled; the program does not replace ongoing local care.
Are labs required?
Not mentioned
The current consent allows clinician-requested testing without establishing a universal included patient laboratory allowance. The older platform agreement describes outside Quest billing and separate diagnostic charges, alongside references to other platforms. Ask which provisions apply to the selected purchase and who pays for required tests. Pharmacy-quality claims do not establish patient bloodwork coverage.
Ready to start with Maves?
Lowest listed price: Sermorelin injection, from $199/mo. Confirm it on the seller’s own site.
What it claims, and what it cites
The homepage uses patient-count and FDA-registered-pharmacy language, alongside protocol benefit claims. Neither establishes FDA approval of a compounded preparation or a controlled outcome study for the bundle. Treatment illustrations also do not identify a pharmacy or verify the contents of a dispensed prescription. Ask for evidence tied to the exact proposed preparation.
How it bills
Current treatment pages separate first-month promotions from ordinary monthly prices. The older January 2022 general agreement describes nonrefundable membership and an approximate 28–30-day renewal cycle. Those older billing provisions need product-specific confirmation; they do not replace the current consent’s clear clinical roles. Obtain the applicable itemized quote and cancellation agreement.
For and against
- For: Individual products and bundles distinguished
- For: Administration routes described
- For: Initial and ordinary prices separated
- For: Ongoing messaging advertised
- Against: Individual clinician still needs confirmation
- Against: Older billing terms need clarification
- Against: Patient-testing allowance unestablished
- Against: Bundle-specific clinical benefit unestablished
The evidence behind what it sells
- Semaglutide Side Effects: What the Wegovy Trials and Label Recorded
- NAD Side Effects: What Injection, IV and Oral Precursor Studies Reported
- Sermorelin Side Effects: What the Trials and FDA Record Report
- Tirzepatide Side Effects: What the Zepbound Label and Trials Recorded
- NMN vs NAD: How the Precursor and the Molecule Itself Compare in Human Studies
- Does Sermorelin Work? What the Human Studies Measured
Right for
Someone comparing a named clinical group’s access with the evidence, monitoring and cost of a combined protocol.
Look elsewhere if
Someone assuming an FDA-registered pharmacy claim means the compound or protocol has received FDA approval.
Other sellers for weight
Premium Health
Also prescribes Semaglutide, Tirzepatide.
MD Live
Also prescribes Semaglutide, Tirzepatide.
Andrew Meds
Also prescribes Semaglutide, Tirzepatide.
Maves
Frequently asked questions
- Does the legal document clearly identify my treating practice?
- The August 2026 consent identifies the Keeva network for clinical care and Homera Health for platform support. Confirm the assigned Keeva entity and clinician.
- Does a bundle prove the ingredients work better together?
- No. A combined offer and its ingredient mechanisms do not establish a clinical outcome study for that particular protocol.
Sources
- Semaglutide introductory and ordinary program prices
- Tirzepatide preparation and ordinary price
- Sermorelin administration and claims
- NAD injection and program price
- Membership, testing liability and clinical-entity references
- Bundle prices and platform claims
- Current Keeva clinical agreement and platform relationship
See what Maves prescribes today
Maves sets its own prices, plans and the states it serves. Check them before you start.